Tags

Type your tag names separated by a space and hit enter

SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Eur Heart J. 2020 05 14; 41(19):1801-1803.EH

Links

Publisher Full Text
ncbi.nlm.nih.gov
academic.oup.com
PMC Free PDF
Aggregator Full Text

Authors+Show Affiliations

Kuster GM
Clinic of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. Department of Biomedicine, University Hospital Basel and University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
Pfister O
Clinic of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. Department of Biomedicine, University Hospital Basel and University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
Burkard T
Clinic of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. Hypertension Clinic, Medical Outpatient Clinic, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
Zhou Q
Clinic of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
Twerenbold R
Clinic of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, Spitalstrasse 2, 4056 Basel, Switzerland.
Haaf P
Clinic of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
Widmer AF
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
Osswald S
Clinic of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32196087

Clinical Trial Links

The McGill RAAS-COVID-19 Trial

Citation

Kuster, Gabriela M., et al. "SARS-CoV2: Should Inhibitors of the Renin-angiotensin System Be Withdrawn in Patients With COVID-19?" European Heart Journal, vol. 41, no. 19, 2020, pp. 1801-1803.
Kuster GM, Pfister O, Burkard T, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020;41(19):1801-1803.
Kuster, G. M., Pfister, O., Burkard, T., Zhou, Q., Twerenbold, R., Haaf, P., Widmer, A. F., & Osswald, S. (2020). SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? European Heart Journal, 41(19), 1801-1803. https://doi.org/10.1093/eurheartj/ehaa235
Kuster GM, et al. SARS-CoV2: Should Inhibitors of the Renin-angiotensin System Be Withdrawn in Patients With COVID-19. Eur Heart J. 2020 05 14;41(19):1801-1803. PubMed PMID: 32196087.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? AU - Kuster,Gabriela M, AU - Pfister,Otmar, AU - Burkard,Thilo, AU - Zhou,Qian, AU - Twerenbold,Raphael, AU - Haaf,Philip, AU - Widmer,Andreas F, AU - Osswald,Stefan, PY - 2020/03/11/received PY - 2020/03/14/revised PY - 2020/3/21/pubmed PY - 2020/3/21/medline PY - 2020/3/21/entrez SP - 1801 EP - 1803 JF - European heart journal JO - Eur Heart J VL - 41 IS - 19 SN - 1522-9645 UR - https://www.unboundmedicine.com/medline/citation/32196087/full_citation L2 - https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehaa235 DB - PRIME DP - Unbound Medicine ER -